Advertisement.

ZVSA Projected Dividend Yield

Com Par $0.001/ZyVersa Therapeutics Inc ( NASDAQ : ZVSA )

ZyVersa Therapeutics is a clinical stage specialty biopharmaceutical company with two licensed proprietary product platforms. Co.'s focus is on renal and inflammatory diseases. The lead candidate in Co.'s renal pipeline is a Phase 2a-ready cholesterol efflux mediator, VAR 200, for focal segmental glomerulosclerosis (FSGS), an orphan renal disease. VAR 200 mediates removal of excess renal cholesterol and lipids that damage the kidneys and has potential to reduce proteinuria and delay disease progression. For treatment of inflammatory diseases, Co. is developing a monoclonal antibody that inhibits inflammasome ASC (IC 100).

20 YEAR PERFORMANCE RESULTS

ZVSA Dividend History Detail
ZVSA Dividend News
ZVSA Competitors News

# of Shares: 0

Closing Price: 1.05

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000